AbRegen is a preclinical stage biotechnology company that specialises in the development of antibody-based therapeutics for tissue repair applications. AbRegen owns a broad intellectual property portfolio related to the modulation of Flightless I, a key regulator of cell growth and migration. The t...See more
Headquarters:
Australia
Company Type:
SME
Company size:
1-10 Employees
Employees by Department
- The Rest (1)
- Total (1)
Key Decision Makers
Financials
LOW
spending power
Discover More Companies
Lookalike companies
Featured Lists
- SMEs in Singapore
- MNCs / Large Enterprises in Singapore
Frequently Asked Questions (FAQ)
- What is the funding status of ABREGEN?
- Where is ABREGEN's headquarter?
- What ABREGEN's spending power?
- Does ABREGEN have a presence in the domain it operates in?

